MarketWatch7m
Roche Says Prasinezumab Missed Primary Goal in Mid-Stage Study
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Atos Completes Financial Restructuring
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
China Condemns EU Sanctions on Chinese Companies Over Russia-Ukraine War
The EU said it has for the first time imposed "fully-fledged" sanctions on Chinese actors that supplied drone components and microelectronic components in support of Russia's war against Ukraine.
Tesla’s stock should be bought on pullbacks for all these reasons, analyst says
Shares of Tesla Inc. fell Wednesday, a rarity this month, but that could actually help make them more attractive for ...
It’s ‘the worst tax deal in America’ — but you still have time to fix it. Here’s how.
Reporting large amounts of income on a W-2 form can set up people for a big tax bill, but there are strategies to trim that.
YTL Power Shares Rise Sharply After Antigraft Agency Clears Subsidiary of Wrongdoing
YTL Power International shares rose sharply after Malaysia's anticorruption agency cleared a company subsidiary of wrongdoing.
Micron’s stock skids as AI momentum doesn’t make up for pressures elsewhere
The memory-chip company cited weakness in consumer-facing markets but momentum in higher-margin areas and those levered to AI ...
MillerKnoll’s stock sinks on outlook, but company says bigger orders signal bigger focus on office space
Shares of MillerKnoll Inc. slid after hours on Wednesday after the furniture maker trimmed its full-year profit outlook, ...
MarketWatch5h
Feds accuse CVS of facilitating unlawful sale of prescription opioids
The Justice Department unsealed a civil complaint Wednesday alleging CVS Pharmacy Inc. and various subsidiaries filled ...
Why stocks and bonds slumped — and market volatility soared — after Fed meeting
Stocks and bonds sold off after the Federal Reserve ended its policy meeting Wednesday with a new set of economic projections ...
Mesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- Update
After the bell, the company's ADRs were trading 22% higher, at $14.98. They ended the day's regular session with a 2% loss, closing at $12.25. Mesoblast said it develops allogeneic (off-the-shelf) ...
MarketWatch7h
Woodside, Chevron Agree to Asset Swap -- Update
Australia's Woodside Energy has agreed to an asset swap with U.S. oil company Chevron that it said will simplify its business and support investor returns. As part of the deal, Woodside will hand ...